Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Clearmind Medicine (Nasdaq: CMND) has signed a definitive agreement to acquire a 51% majority stake in Charging Robotics, a developer of wireless EV charging systems for automated parking facilities and robotaxis, for an aggregate purchase price of $2.5 million. As a condition to closing, Clearmind must also extend a $1.5 million loan to Charging Robotics bearing 4% annual interest, due three years after closing and automatically extended if the target cannot generate sufficient cash flow to repay. The deal is an unusual diversification for a clinical-stage psychedelic biotech focused on alcohol use disorder therapeutics, directing cash into an unrelated EV-charging business.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.